Novel salivary biomarkers of Alzheimer's disease identified by integrated metabolomics and microbiomics analysis
Clinical Oral Investigations · 21.05.2026 · 30 (6)
DOI: 10.1007/s00784-026-06933-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oral Investigations, online erschienen am 21.05.2026. Verfasst von Hongxu Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Zhejiang Normal University, Jinhua, 321004, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Metabolomics, Saliva, Microbiota. Die Arbeit nennt 98 Literaturangaben. Gefördert von: the Natural Science Foundation of Zhejiang Province, the National Key Research and Development Program of China.
Themen: Demenz
Abstract (Originalsprache)
OBJECTIVES: Alzheimer's disease (AD) and mild cognitive impairment (MCI) represent significant health challenges, with identification of biomarkers from non-invasive biofluid critical for large-scale screening and effective intervention. MATERIAL AND METHODS: In this study, we performed a comprehensive analysis integrating non-targeted metabolomics and 16S rDNA sequencing of saliva samples from 3 age and sex-matched groups containing 18 AD patients, 15 MCI individuals and 19 healthy controls (HC). RESULTS: Salivary metabolites including histamine (biogenic amine), carveol (monoterpene), and 2-phosphoglycerate (glycolytic intermediate) were significantly altered in AD patients. In addition, L-glutamic acid (excitatory neurotransmitter) levels were notably reduced in MCI patients, suggesting its potential as a biomarker for MCI. Microbial analysis revealed a decrease in the abundance of Actinomyces and Stomatobaculum in AD patients. In contrast, MCI patients exhibited a reduction in Atopobium and Actinomyces, along with an increase in Gemella and Peptostreptococcus compared to HC. An integrated analysis of microbiota and metabolites uncovered significant correlations, such as a positive correlation between Lactobacillus crispatus and GABA in AD patients, and an association between Klebsiella pneumoniae and multiple metabolites in AD patients. Additionally, MCI patients exhibited a higher abundance of "potentially pathogenic" microbiota species, highlighting a distinct microbiome profile. CONCLUSIONS: Our findings revealed distinct metabolic and microbiomic alterations across the groups. CLINICAL RELEVANCE: These findings suggest that saliva may harbor valuable biomarkers for the early diagnosis of AD and MCI. Moreover, our results underscore the involvement of the "oral-brain axis" in the pathogenesis of neurodegenerative diseases, offering new insights into potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Zhejiang Normal University, Jinhua, 321004, China.
- Department of Gerontology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, China.
- Department of General Practice, Xiguan Community Healthcare Center, Jinhua, 321017, China.
- State Key Laboratory for Quality and Safety of Agro-Products, Institute of Agro-Product Safety and Nutrition, Zhejiang Academy of Agricultural Sciences, Hangzhou, 310021, China.
- University Hospital, Zhejiang Normal University, Jinhua, 321004, China.
- Department of Pediatrics, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, China. qianxubo@qq.com.
Förderung
- the Natural Science Foundation of Zhejiang Province
- the National Key Research and Development Program of China
Zitieren
APA
Chen, H., Chen, H., Xie, L., Jiang, K., Xia, E., Mao, J., Liu, Z., Li, X., Xiao, Y., Qian, X., & Jin, Z. (2026). Novel salivary biomarkers of Alzheimer's disease identified by integrated metabolomics and microbiomics analysis. Clinical Oral Investigations, 30(6). https://doi.org/10.1007/s00784-026-06933-5
Vancouver
Chen H, Chen H, Xie L, Jiang K, Xia E, Mao J, et al. Novel salivary biomarkers of Alzheimer's disease identified by integrated metabolomics and microbiomics analysis. Clinical Oral Investigations. 2026;30(6). doi:10.1007/s00784-026-06933-5
BibTeX
@article{Chen2026,
author = {Chen, Hongxu and Chen, Huilan and Xie, Lingling and Jiang, Kaiyi and Xia, Enzhu and Mao, Jiaqi and Liu, Zhendong and Li, Xuhua and Xiao, Yingping and Qian, Xubo and Jin, Zhigang},
title = {Novel salivary biomarkers of Alzheimer's disease identified by integrated metabolomics and microbiomics analysis},
journal = {Clinical Oral Investigations},
year = {2026},
volume = {30},
number = {6},
doi = {10.1007/s00784-026-06933-5}
}
EUVIMED